Last reviewed · How we verify
Gustave Roussy Cancer Profiling (STING)
The objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.
Details
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 20000 |
| Start date | Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue May 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Solid Tumor, Unspecified, Adult
Interventions
- Biopsy
Countries
France